Update on the clinical use of the low-molecular-weight heparin, parnaparin

Parnaparin is a low-molecular-weight heparin that has widely shown its efficacy and safety in prevention of venous thromboembolism, in the treatment of chronic venous disorders, and in the treatment of venous and arterial (stable and unstable angina, acute ST-segment elevation myocardial infarction)...

Descripción completa

Detalles Bibliográficos
Autores principales: Camporese, Giuseppe, Bernardi, Enrico, Noventa, Franco
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762431/
https://www.ncbi.nlm.nih.gov/pubmed/19851520

Ejemplares similares

Ejemplares similares